Skip to main content
. 2023 Oct 11;10(6):1637–1653. doi: 10.1007/s40744-023-00592-8

Fig. 4.

Fig. 4

Mean BASDAI component scores (observed data) through week 100 in patients from DISCOVER-2 with active psoriatic arthritis and investigator-verified, imaging-confirmed sacroiliitis. BASDAI Bath Ankylosing Spondylitis Disease Activity Index, GUS guselkumab, PBO placebo, Q4W/Q8W every 4/8 weeks